| __timestamp | Merck & Co., Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 16768000000 | 5758000 |
| Thursday, January 1, 2015 | 14934000000 | 8423000 |
| Friday, January 1, 2016 | 13891000000 | 11986000 |
| Sunday, January 1, 2017 | 12775000000 | 15215000 |
| Monday, January 1, 2018 | 13509000000 | 15356000 |
| Tuesday, January 1, 2019 | 14112000000 | 16660000 |
| Wednesday, January 1, 2020 | 13618000000 | 52459000 |
| Friday, January 1, 2021 | 13626000000 | 75061000 |
| Saturday, January 1, 2022 | 17411000000 | 87221000 |
| Sunday, January 1, 2023 | 16126000000 | 83779000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Merck & Co., Inc. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Merck's cost of revenue fluctuated, peaking in 2022 with a 27% increase from its lowest point in 2017. In contrast, Supernus Pharmaceuticals demonstrated a remarkable growth trajectory, with its cost of revenue surging by over 1,400% from 2014 to 2023. This stark contrast highlights the differing scales and operational strategies of these two companies. While Merck operates on a much larger scale, Supernus's rapid growth suggests a dynamic approach to market challenges. Understanding these trends provides valuable insights into the financial strategies and market positioning of these pharmaceutical giants.
Merck & Co., Inc. vs Zoetis Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Merck & Co., Inc. and Intra-Cellular Therapies, Inc.
Analyzing Cost of Revenue: Merck & Co., Inc. and Corcept Therapeutics Incorporated
Comparing Cost of Revenue Efficiency: Merck & Co., Inc. vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Merck & Co., Inc. vs MorphoSys AG
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Corcept Therapeutics Incorporated vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Supernus Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: Supernus Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.